Elevate Clinical Research, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2025 | $1 M | No. 1 | Under $2 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Elevate Clinical Research, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2026).
SEC Form D · Feb 2026
The industry group it chose in its notices: Other Health Care.
SEC Form D · Feb 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Elevate Clinical Research, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Devora Henderson | Executive officer | Feb 2026 |
| Devora Henderson | Director | Feb 2026 |
| Patrick Feeney | Director | Feb 2026 |